Tirzepatide gains US Food and Drug Administration approval for the management of obstructive sleep apnea: implications for oral health care providers
The LDL lowering we see with statins is far greater than with GLP-1's
doi: 10.3389/fimmu.2026.1845654 Received 02 April 2026 Revised 07 April 2026 Accepted 21 April 2026 Published 11 May 2026 Volume 17 - 2026 Edited by Venkata Ramireddy Narala, Yogi Vemana University, India Reviewed by Farrah Kheradmand, Baylor College of Medicine, United States Homayon Ghiasi, Cedars Sinai Medical Center, United States Updates Copyright 2026 Cain, Hurrell, Shen, Speliakos and Akbari
* If you experience any severe side effects, seek immediate medical attention
We take the stress out of understanding your benefits, allowing you to simply focus on achieving your wellness goals
Physiology and Behav